Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.47 USD | -1.04% | +9.95% | +132.30% |
Financials (USD)
Sales 2024 * | 358M | Sales 2025 * | 414M | Capitalization | 2.45B |
---|---|---|---|---|---|
Net income 2024 * | 83M | Net income 2025 * | 127M | EV / Sales 2024 * | 6.86 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 5.92 x |
P/E ratio 2024 * |
30
x | P/E ratio 2025 * |
19.6
x | Employees | 624 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.47% |
Latest transcript on ADMA Biologics, Inc.
1 day | +0.86% | ||
1 week | +11.60% | ||
Current month | +10.79% | ||
1 month | +53.11% | ||
3 months | +72.88% | ||
6 months | +176.96% | ||
Current year | +134.07% |
Managers | Title | Age | Since |
---|---|---|---|
Adam Grossman
CEO | Chief Executive Officer | 47 | 06-06-01 |
Compliance Officer | 37 | 10-12-31 | |
Skyler Bloom
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Lawrence Guiheen
BRD | Director/Board Member | 73 | 12-07-23 |
Bryant Fong
BRD | Director/Board Member | 51 | 12-04-30 |
Steven Elms
CHM | Chairman | 60 | 06-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.03% | 1,487 M€ | +8.44% | - | |
0.01% | 9 M€ | +10.34% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 10.5 | -0.76% | 515 998 |
24-06-06 | 10.58 | +0.86% | 2,752,704 |
24-06-05 | 10.49 | +3.96% | 3,077,882 |
24-06-04 | 10.09 | +2.85% | 4,608,116 |
24-06-03 | 9.81 | +2.72% | 4,735,437 |
Delayed Quote Nasdaq, June 06, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+134.07% | 2.45B | |
+0.82% | 93.19B | |
0.00% | 39.62B | |
-10.35% | 33.78B | |
+64.64% | 26.82B | |
-16.15% | 15.35B | |
-6.98% | 13.13B | |
-11.77% | 11.6B | |
-49.19% | 10.26B | |
+7.57% | 9.43B |
- Stock Market
- Equities
- ADMA Stock